Curtana Pharmaceuticals
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4200 Marathon Blvd Ste 200, Austin, Texa...Phone Number
(512) 900-3696Website
www.curtanapharma.comRevenue
<$5 MillionIndustry
About Curtana Pharmaceuticals
Curtana Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative therapies for brain cancer patients, particularly targeting adult and pediatric brain cancers. Their lead investigational therapy, CT-179, is designed to eradicate cancer stem cells and reverse tumor-driven immune suppression, addressing the challenges of recurrence in aggressive malignancies like glioblastoma. The company aims to change the treatment paradigm by targeting the OLIG2 transcription factor, which plays a crucial role in tumor resilience and immune evasion. With a commitment to improving patient outcomes, Curtana is advancing its pipeline through various clinical trials and has received recognition for its potential breakthroughs in pediatric brain cancer treatment.Explore more
Curtana Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Curtana Pharmaceuticals
Compare insights from companies similar to Curtana Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Curtana Pharmaceuticals Tech Stack
A closer look at the technologies used by Curtana Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Curtana Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Curtana Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative therapies for brain cancer patients, particularly targeting adult and pediatric brain cancers. Their lead investigational therapy, CT-179, is designed to eradicate cancer stem cells and reverse tumor-driven immune suppression, addressing the challenge... Read More
